UTMD (Utah Medical) Market Value to Book Value Ratio

Utah Medical (UTMD) - corporate logo

Utah Medical Products maintains an impeccable reputation as a creator of precision obstetric equipment, earning the absolute trust of medical professionals in its reliability. The business leverages its status as a recognized expert in equipping neonatology and gynecology offices, guaranteeing consistent product quality. The current metric stands at 1.88, and the stock price trend on the GURU.Markets platform confirms physicians' confidence in the safety of these women's health instruments.

UTMD - Utah Med Market-to-Book Ratio over the range 07/04/2022 - 10/28/2026
Manufactured products of Utah Medical Products Inc.

This indicator reflects the market-to-book value premium, determining the extent to which the business is overvalued relative to its book value. Stable plant utilization and the certification of Utah Medical Products (UTMD) molding lines support the capital base; therefore, this market capitalization-to-book value chart allows for an assessment of how the market currently prices in the long-term efficiency of the company's production infrastructure.

Direct competitors

Market Capitalization to Book Value Ratio Intuitive Surgical|DHR (danaher.com) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAAR Surgical Co. STAA|Market Cap to Net Assets Ratio niagenbioscience.com|Market Value to Book Value ZimVie Corp ZIMV|Market Capitalization to Book Value Ratio ANGO (AngioDynamics, Inc.)|CERS: Market Capitalization to Book Value|Market Value to Book Value Ratio Teknova|MGRM (Monogram Technologies Inc.) - Capitalization to Book Value Ratio|STSS: Market Value to Book Value Ratio|Market Capitalization to Book Value InfuSystem Inc (INFU)|Market Cap to Net Assets Ratio KORU Medical Systems|Market Cap to Book Value Multiple NYXH (nyxoah.com)|Market Value to Book Value Ratio Microbot Medical|PDEX - Market Value to Book Value|Zentek Limited - Market Cap to Net Assets Ratio|ELUT: Market Capitalization to Book Value Ratio|MLSS (Milestone Scientific) - Market Value to Book Value Ratio|nexgel.com (NXGL) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio RVP (Retractable Technologies Inc.)|Market-to-Book Ratio HBIO|Market Value to Book Value Ratio Femasys Corp FEMY|Capitalization to Book Value Ratio meihuamed.com MHUA|Market Cap to Net Assets Ratio Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NeuroMetrix Inc (NURO) - Market Capitalization to Book Value